Duarte RF, Labopin M, Bader P, et al. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant. 2019;54(10):1525–52.
Magenau J, Couriel DR. Hematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how. Curr Oncol Rep. 2013;15(5):436–44.
Article CAS PubMed Google Scholar
Passweg JR, Baldomero H, Basak GW, et al. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant. 2019;54(10):1575–85.
Article CAS PubMed PubMed Central Google Scholar
Sarantopoulos S, Cardones AR, Sullivan KM. How I treat refractory chronic graft-versus-host disease. Blood. 2019;133(11):1191–200.
Article CAS PubMed PubMed Central Google Scholar
Arai S, Arora M, Wang T, et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2015;21(2):266–74.
Arora M, Cutler CS, Jagasia MH, et al. Late acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22(3):449–55.
Boyiadzis M, Arora M, Klein JP, et al. Impact of chronic graft-versus-host disease on late relapse and survival on 7489 patients after myeloablative allogeneic hematopoietic cell transplantation for leukemia. Clin Cancer Res. 2015;21(9):2020–8.
Sun CL, Francisco L, Kawashima T, et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood. 2010;116(17):3129–39 (quiz 3377).
Sun C-L, Kersey JH, Francisco L, et al. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the Bone Marrow Transplantation Survivor Study. Biol Blood Marrow Transplant. 2013;19(7):1073–80.
Article PubMed PubMed Central Google Scholar
Atsuta Y, Hirakawa A, Nakasone H, et al. Late mortality and causes of death among long-term survivors after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2016;22(9):1702–9.
Solh MM, Bashey A, Solomon SR, et al. Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients. Bone Marrow Transplant. 2018;53(5):576–83.
Article CAS PubMed Google Scholar
Lee SJ, Kim HT, Ho VT, et al. Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant. 2006;38(4):305–10.
Article CAS PubMed Google Scholar
Fiuza-Luces C, Simpson RJ, Ramirez M, Lucia A, Berger NA. Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients. Bone Marrow Transplant. 2016;51(1):13–26.
Article CAS PubMed Google Scholar
Kurosawa S, Yamaguchi T, Oshima K, et al. Resolved versus active chronic graft-versus-host disease: impact on post-transplantation quality of life. Biol Blood Marrow Transplant. 2019;25(9):1851–8.
Lee SJ, Onstad L, Chow EJ, et al. Patient-reported outcomes and health status associated with chronic graft-versus-host disease. Haematologica. 2018;103(9):1535–41.
Article PubMed PubMed Central Google Scholar
Fatobene G, Storer BE, Salit RB, et al. Disability related to chronic graft-versus-host disease after alternative donor hematopoietic cell transplantation. Haematologica. 2019;104(4):835–43.
Article CAS PubMed PubMed Central Google Scholar
Hamilton BK, Rybicki L, Arai S, et al. Association of socioeconomic status with chronic graft-versus-host disease outcomes. Biol Blood Marrow Transplant. 2018;24(2):393–9.
Hamilton BK, Storer BE, Wood WA, et al. Disability related to chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2020;26(4):772–7.
World Health Organization. International Classification of Functioning, Disability and Health (ICF). Available at: https://www.who.int/classifications/international-classification-of-functioning-disability-and-health. Accessed February 9, 2024.
Yu J, Hamilton BK, Turnbull J, et al. Patient-reported symptom burden and impact on daily activities in chronic graft-versus-host disease. Cancer Med. 2022;12:3623–33.
Article PubMed PubMed Central Google Scholar
Yu J, Khera N, Turnbull J, et al. Impact of chronic graft-versus-host disease (GVHD) on patients’ employment, income, and informal caregiver burden: findings from the Living With Chronic GVHD Patient Survey. Transplant Cell Ther. 2023;29(7):470.e1-470.e9.
Lee S, Cook EF, Soiffer R, Antin JH. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2002;8(8):444–52.
Jacobs JM, Fishman S, Sommer R, et al. Coping and modifiable psychosocial factors are associated with mood and quality of life in patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2019;25(11):2234–42.
El-Jawahri A, Pidala J, Khera N, et al. Impact of psychological distress on quality of life, functional status, and survival in patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2018;24(11):2285–92.
Mitchell SA, Leidy NK, Mooney KH, et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant. 2010;45(4):762–9.
Article CAS PubMed Google Scholar
Kurosawa S, Oshima K, Yamaguchi T, et al. Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2017;23(10):1749–58.
Syrjala KL, Artherholt SB, Kurland BF, et al. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. J Clin Oncol. 2011;29(17):2397–404.
Article PubMed PubMed Central Google Scholar
Syrjala KL, Dikmen S, Langer SL, Roth-Roemer S, Abrams JR. Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood. 2004;104(10):3386–92.
Article CAS PubMed Google Scholar
Lindsay S, Varahra A, Ahmed H, et al. Exploring the relationships between race, ethnicity, and school and work outcomes among youth and young adults with disabilities: a scoping review. Disabil Rehabil. 2022;44(25):8110–29.
US Bureau of Labor Statistics. Ability to work from home: evidence from two surveys and implications for the labor market in the COVID-19 pandemic. Available at: https://www.bls.gov/opub/mlr/2020/article/ability-to-work-from-home.htm. Accessed February 9, 2024.
US Bureau of Labor Statistics. Job Flexibilities and Work Schedules—2017–2018 Data From the American Time Use Survey Available at: https://www.bls.gov/news.release/pdf/flex2.pdf. Accessed February 9, 2024.
Census Bureau Releases New Educational Attainment Data: Press Release Number CB22-TPS.02. United Stated Census Bureau. Available at: https://www.census.gov/newsroom/press-releases/2022/educational-attainment.html. Accessed May 17, 2023.
Disability Rates and Employment Status by Educational Attainment. The National Center for Education Statistics (NCES). Available. Accessed May 17, 2024.
Racial/Ethnic Disparities in Disability by Health Condition. United States Census Bureau. Available at: https://www.census.gov/library/stories/2023/07/disparities-in-disabilities.html. Accessed May 17, 2024.
留言 (0)